Zhejiang Huahai Pharmaceutical Co., Ltd. (600521.SS) SHH

Currency In CNY

AD

Valuation

Market Cap25.17B
Enterprise Value32.33B
P/E Ratio59.67
PEG Ratio-0.87
Price/Sales Ratio2.57
Price/Book Ratio2.22
Enterprise/Revenue3.42
Enterprise/EBITDA47.26

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.04
Operating Margin0.04
AD

Management Effectiveness

Return On Assets0.02
Return On Equity0.04

Income Statement

Revenue8.54B
Revenue/Share5.74
Gross Profit4.7B
EBITDA1.59B
Net Income266.94M
Diluted EPS0.18

Balance Sheet

Total Cash1.97B
Total Cash/Share1.33
Total Debt9.21B
Total Debt/Equity0.94
Current Ratio1.01
Book Value Per Share6.61

Price History

52-Week Change-25.47
52-Week High27.97
52-Week Low13.76
Moving Average 50 Days15.86
Moving Average 200 Days17.3

Statistics

Average Volume25.01M
Shares Outstanding1.5B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.1
Trailing Annual Dividend Yield0.68
Payout Ratio0.38
Last Split Factor11:10
Last Split DateJune 08, 2020
AD